An increased loading dose of ondansetron: a North European, double-blind randomised study in children, comparing 5 mg/m2 with 10 mg/m2
- 30 September 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (10) , 1744-1748
- https://doi.org/10.1016/0959-8049(96)00157-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Ondansetron as Prophylaxis for Chemotherapy and Radiotherapy-Induced Emesis in ChildrenOncology, 1992
- 5-HT3 antagonist ondansetron--an effective outpatient antiemetic in cancer treatment.Archives of Disease in Childhood, 1990
- Comparison of the 5-Hydroxytryptamine3(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced EmesisNew England Journal of Medicine, 1990
- Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy.Journal of Clinical Oncology, 1985
- Paradoxical effects of prophylactic phenothiazine antiemetics in children receiving chemotherapy.Journal of Clinical Oncology, 1984
- Side effects of metoclopramide as an antiemetic in childhood cancer chemotherapyThe Journal of Pediatrics, 1984
- REFUSAL OF FURTHER CANCER CHEMOTHERAPY DUE TO ANTIEMETIC DRUGThe Lancet, 1984
- The Pharmacology and Clinical Effectiveness of Phenothiazines and Related Drugs for Managing Chemotherapy-induced EmesisDrugs, 1983
- Metoclopramide poisoning in children.Archives of Disease in Childhood, 1981
- Dystonic Reactions in Children Caused by MetoclopramideArchives of Disease in Childhood, 1970